PyInvesting

Market research

EUZ.F Eckert & Ziegler Strahlen- und Medizintechnik AG

F EUR Healthcare

Latest close

14.88 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
939M
P/E ratio
18.52
Analyst target
21.9333
Dividend yield
1.5%
Beta
1.33

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Eckert & Ziegler Strahlen- und Medizintechnik AG is currently in a long term uptrend where the price is trading 58.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.3.

Eckert & Ziegler Strahlen- und Medizintechnik AG's total revenue sank by 4.5% to $43M since the same quarter in the previous year.

Its net income has increased by 55.0% to $5M since the same quarter in the previous year.

Finally, its free cash flow grew by 43.3% to $16M since the same quarter in the previous year.

Based on the above factors, Eckert & Ziegler Strahlen- und Medizintechnik AG gets an overall score of 4/5.